Charles River Laboratories International (CRL) Net Cash Flow (2009 - 2025)

Charles River Laboratories International's Net Cash Flow history runs 17 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 61.39% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at -$8.4 million (up 86.33% YoY), while the FY2025 annual figure was -$8.4 million, up 86.33% from the prior year.
• Net Cash Flow for Q4 2025 stood at $2.8 million, down from $27.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $227.0 million in Q1 2021, with the low at -$249.6 million in Q2 2021.
• The 5-year median for Net Cash Flow is $1.4 million (2023), against an average of -$3.5 million.
• The sharpest annual moves came in 2021 and 2024: Net Cash Flow soared 311.29% in 2021, then sank 314771.43% in 2024.
• Charles River Laboratories International's Net Cash Flow stood at $19.6 million in 2021, then jumped by 54.06% to $30.2 million in 2022, then jumped by 251.64% to $106.1 million in 2023, then plunged by 93.05% to $7.4 million in 2024, then plunged by 61.39% to $2.8 million in 2025.
• Business Quant data shows CRL's Net Cash Flow at $2.8 million in Q4 2025, $27.5 million in Q3 2025, and -$59.7 million in Q2 2025.